<VariationArchive RecordType="classified" VariationID="60710" VariationName="NM_001271.4(CHD2):c.1809+1del" VariationType="Deletion" Accession="VCV000060710" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2021-04-18" MostRecentSubmission="2021-04-18">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="75272" VariationID="60710">
      <GeneList>
        <Gene Symbol="CHD2" FullName="chromodomain helicase DNA binding protein 2" GeneID="1106" HGNC_ID="HGNC:1917" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q26.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="92900324" stop="93027996" display_start="92900324" display_stop="93027996" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="93443550" stop="93571236" display_start="93443550" display_stop="93571236" Strand="+" />
          </Location>
          <OMIM>602119</OMIM>
          <Haploinsufficiency last_evaluated="2019-10-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CHD2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-10-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CHD2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001271.4(CHD2):c.1809+1del</Name>
      <CanonicalSPDI>NC_000015.10:92955511:GG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q26.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="92955512" stop="92955512" display_start="92955512" display_stop="92955512" variantLength="1" positionVCF="92955511" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="93498742" stop="93498742" display_start="93498742" display_stop="93498742" variantLength="1" positionVCF="93498741" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.92955513del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.92955513del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.93498743del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.93498743del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012826.2" sequenceAccession="NG_012826" sequenceVersion="2" change="g.60193del">
            <Expression>NG_012826.2:g.60193del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001271.4" sequenceAccession="NM_001271" sequenceVersion="4" change="c.1809+1del" MANESelect="true">
            <Expression>NM_001271.4:c.1809+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1425" sequenceAccession="LRG_1425">
            <Expression>LRG_1425:g.60193del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1425t1" sequenceAccession="LRG_1425t1">
            <Expression>LRG_1425t1:c.1809+1del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA144637" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="602119.0001" DB="OMIM" />
        <XRef Type="rs" ID="397514739" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001271.4(CHD2):c.1809+1del AND Developmental and epileptic encephalopathy 94" Accession="RCV000054507" Version="4">
        <ClassifiedConditionList TraitSetID="11671">
          <ClassifiedCondition DB="MedGen" ID="C3809278">Developmental and epileptic encephalopathy 94</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2012-11-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2012-11-10" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-04-18" MostRecentSubmission="2021-04-18">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23020937</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="11671" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18237" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Epileptic encephalopathy, childhood-onset</ElementValue>
                <XRef ID="MONDO:0014150" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy 94</ElementValue>
                <XRef ID="MONDO:0014150" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DEE94</ElementValue>
                <XRef Type="MIM" ID="615369" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13197" />
                <XRef ID="13197" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">CHD2-related neurodevelopmental disorders are characterized by early-onset epileptic encephalopathy (i.e., refractory seizures and cognitive slowing or regression associated with frequent ongoing epileptiform activity). Seizure onset is typically between ages six months and four years. Seizure types typically include drop attacks, myoclonus, and rapid onset of multiple seizure types associated with generalized spike-wave on EEG, atonic-myoclonic-absence seizures, and clinical photosensitivity. Intellectual disability and/or autism spectrum disorders are common.</Attribute>
                <XRef ID="NBK333201" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">26677509</ID>
                <ID Source="BookShelf">NBK333201</ID>
              </Citation>
              <XRef ID="1942" DB="Orphanet" />
              <XRef ID="2382" DB="Orphanet" />
              <XRef ID="C3809278" DB="MedGen" />
              <XRef ID="MONDO:0014150" DB="MONDO" />
              <XRef Type="MIM" ID="615369" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="142561" SubmissionDate="2021-04-14" DateLastUpdated="2021-04-18" DateCreated="2013-08-23">
        <ClinVarSubmissionID localKey="602119.0001_DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 94" title="CHD2, 1-BP DEL, 1809G_DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 94" />
        <ClinVarAccession Accession="SCV000082985" DateUpdated="2021-04-18" DateCreated="2013-08-23" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-11-10">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a German girl (MS134) with developmental and epileptic encephalopathy-94 (DEE94; 615369), Rauch et al. (2012) identified a de novo heterozygous 1-bp deletion (c.1809delG) in the CHD2 gene, resulting in a frameshift and premature termination (Thr604LeufsTer19). The mutation, which was found by exome sequencing and confirmed by Sanger sequencing, was not found in either parent. The patient had delayed psychomotor development with an IQ of 50-69 and onset of absence seizures at age 5 years. She was ascertained from a large cohort of 51 patients with intellectual disability who underwent exome sequencing. Rauch et al. (2012) postulated haploinsufficiency as the disease mechanism.</Attribute>
              <Citation>
                <ID Source="PubMed">23020937</ID>
              </Citation>
              <XRef DB="OMIM" ID="615369" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CHD2" />
          </GeneList>
          <Name>CHD2, 1-BP DEL, 1809G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 1809G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="602119.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 94</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="142561" TraitType="Disease" MappingType="Name" MappingValue="DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 94" MappingRef="Preferred">
        <MedGen CUI="C3809278" Name="Developmental and epileptic encephalopathy 94" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

